The outbreak of the coronavirus crisis brought international travel to a temporary standstill. The industry recovered strongly last year, as evidenced by the results of Zurich Airport and duty-free specialist Avolta. However, there is still room for improvement.
Swiss insurers have a reputation for being reliable and generous dividend payers. Their equities are therefore well suited as underlying for yield enhancement products such as barrier reverse convertibles.
Global stock markets have had a buoyant start to the year. For investors who want to stay invested in equities while limiting losses, a cushion participation certificate is an attractive option.
Cocoa prices have soared following crop failures in West Africa, and the commodity is now more expensive than ever. Chocolate manufacturers have not yet fully passed on the price increases to consumers.
Indices: Geographical diversification and yield enhancement.
The air is getting thinner for US technology titans. After last year's stock price rally, investors expect nothing less than perfection from the «Magnificent Seven», as a review of the quarterly results reveals.
About four months ago, Sandoz was spun off from its parent company Novartis. The success of the Swiss drugmaker is likely to be determined by its performance in the growing biosimilars market.
After a difficult few months, Lonza shares have made a brilliant start to the new year.
Tesla's disappointing quarterly results put pressure on the shares of the electric car manufacturer.
19.313% p.a. ZKB Barrier Reverse Convertible, 10.01.2025 on worst of LOGN SE/AMS SE 135804789 / CH1358047897 |
ZKB Barrier Reverse Convertible on worst of CrowdStrike Holdings Inc/Snowflake Inc 132911907 / CH1329119072 |
15.6282% p.a. ZKB Barrier Reverse Convertible, 19.02.2025 auf AMS SE 132914049 / CH1329140490 |
16.0994% p.a. ZKB Barrier Reverse Convertible, 19.02.2025 auf AMS SE 135803773 / CH1358037732 |
ZKB Autocallable Reverse Convertible on worst of Adobe Inc/Datadog Inc/Snowflake Inc 132911170 / CH1329111707 |